Group B streptococcus

Lancet

Volumn 353, Issue 9146, 1999, Pages 51-56

  Schuchat, Anne ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEPHALOSPORIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G; POLYSACCHARIDE VACCINE;

AUSTRALIA; COST EFFECTIVENESS ANALYSIS; DRUG DEVELOPMENT; FEMALE; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN; NORTH AMERICA; PERINATAL MORBIDITY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SEROTYPE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

EID: 0033514078     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)07128-1     Document Type: Review

References (33)

1. Regan J.A., Klebanoff M.A., Nugent RPet al. Colonization with group B streptococci in pregnancy and adverse outcome. Am J Obstet Gynecol. 174:1996;1354-1360.
2. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. In: CDC surveillance summaries vol 41 (MMWR 1992; SS-6:25-32 [Nov 20, 1992]).
3. Centers for Disease Control and Prevention. Decreasing incidence of perinatal group B streptococcal disease - United States, 1993-1995. MMWR 1997; 46: 473-77.
4. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996; 45: 1-24 (RR-7).
5. Rouse D.J., Goldenberg R.L., Cliver S.P., Cutter G.R., Mennemeyer S.T., Fargason C.A. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol. 83:1994;483-494.
6. Rosenstein N, Schuchat A, Neonatal GBS Disease Study Group. Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. Obstet Gynecol 1997; 90: 901-06.
7. Centers for Disease Control and Prevention. Adoption of hospital policies for prevention of perinatal group B streptococcal disease - United States, 1997. MMWR 1998; 47: 65-70.
8. Fernandez M., Hickman M.E., Baker C.J. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother. 42:1998;1517-1519.
9. Pearlman M.D., Pierson C.L., Faix R.G. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet Gynecol. 92:1998;258-261.
10. Siegel J.D., Cushion N.B. Prevention of early-onset group B streptococcal disease: another look at single-dose penicillin at birth. Obstet Gynecol. 87:1996;692-698.
11. Joseph T.A., Pyati S.P., Jacobs N. Neonatal early-onset Escherichia coli disease: the effect of intrapartum ampicillin. Arch Pediatr Adolesc Med. 152:1998;35-40.
12. Towers V., Carr M.H., Padilla G., Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol. 179:1998;879-883.
13. Gotoff S.P., Boyer K.M. Prevention of early-onset neonatal group B streptococcal disease. Pediatrics. 99:1997;86-89.
14. Baker C.J. Inadequacy of rapid immunoassays for intrapartum detection of group B streptococcal carriers. Obstet Gynecol. 88:1996;51-55.
15. Burman L.G., Christensen P., Christensen Ket al. Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labour. Lancet. 340:1992;65-69.
16. Taha T.E., Biggar R.J., Broadhead RLet al. Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ. 315:1997;216-219.
17. Lancefield R.C., McCarty M., Everly W.N. Multiple mouse-protective antibodies directed against group B streptococci: special reference to antibodies effective against protein antigens. J Exp Med. 142:1975;165-179.
18. Baker C.J., Kasper D.L. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med. 294:1976;753-756.
19. Kasper D.L., Paoletti L.C., Wessels MRet al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest. 98:1996;2308-2314.
20. Parry S., Strauss J.F. Premature rupture of the fetal membranes. N Engl J Med. 338:1998;63-70.
21. Hillier S.L., Nugent R.P., Eschenbach DAet al. Association between bacterial vaginosis and preterm delivery of a low birth weight infant. N Engl J Med. 333:1995;1737-1742.
22. Klebanoff M.A., Regan J.A., Vijaya Rao Aet al. Outcome of the Vaginal Infections and Prematurity Study: results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci. Am J Obstet Gynecol. 172:1995;1540-1545.
23. Farley M.M., Harvey R.C., Stull Tet al. A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. N Engl J Med. 328:1993;1807-1811.
24. Jackson L.A., Hilsdon R., Farley Met al. Risk factors for group B streptococcal disease in adults. Ann Intern Med. 123:1995;415-420.
25. Temmerman M., Lopita M.I., Sanghvi H.C.G., Sinei S.K.F., Plummer F.A., Piot P. The role of maternal syphilis, gonorrhoea and HIV-1 infections in spontaneous abortion. Int J STD AIDS. 3:1992;418-422.
26. Stoll B.J., Schuchat A. Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J. 17:1998;499-503.
27. Regan J.A., Chao S., James L.S. Premature rupture of membranes, preterm delivery, and group B streptococcal colonization of mothers. Am J Obstet Gynecol. 141:1981;184-186.
28. Thomsen A.C., Morup L., Brogaard Hansen K. Antibiotic elimination of group B streptococci in urine in prevention of preterm labour. Lancet. i:1987;591-593.
29. Sweet R.L., Landers D.V., Walker C., Schacter J. Chlamydia trachomatis infection and pregnancy outcome. Am J Obstet Gynecol. 156:1987;824-833.
30. Moller M., Thomsen A.C., Borch K., Dinesen K., Zdravkovic M. Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women. Lancet. ii:1984;69-70.
31. McKenzie H., Donnet M.L., Howie P.W.S., Patel N.B., Benvie D.T. Risk of preterm delivery in pregnant women with group B streptococcal urinary infections or urinary antibodies to group B streptococcal and E coli antigens. Br J Obstet Gynaecol. 101:1994;107-113.
32. Hastings M.J.G., Easmon C.S.F., Neill J., Bloxham B., Rivers R.P.A. Group B streptococcal colonisation and the outcome of pregnancy. J Infect. 12:1986;23-29.
33. Matorras R., Garcia Perea A., Omenaca f, Usandizaga J.A., Nieto A., Heruzo R. Group B streptococcus and premature rupture of membranes and preterm delivery. Gynecol Obstet Invest. 27:1989;14-18.